Dr Olivier Govaere Professor Dina Tiniakos Professor Alastair Burt Marco Zaki Dr Luca Miele et al. | Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease | 2024 |
|
Dr Luca Miele Professor Helen Reeves
| Rare ATG7 genetic variants predispose patients to severe fatty liver disease | 2022 |
|
Dr Massimo Younes Dr Olivier Govaere Dr Dina Tiniakos Professor Alastair Burt Marco Youssef William Zaki et al. | Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease | 2021 |
|
Dr Luca Miele Professor Quentin Anstee Professor Helen Reeves
| Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores | 2021 |
|
Dr Massimo Younes Dr Olivier Govaere Dr Luca Miele Dr Dina Tiniakos Professor Alastair Burt et al. | Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease | 2020 |
|
Misti McCain Dr Luca Miele Professor Helen Reeves
| Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease | 2019 |
|
Misti McCain Dr Luca Miele Dr Paula Iruzubieta Professor Helen Reeves Professor Quentin Anstee et al. | MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals | 2017 |
|
Dr Lucy Walker Professor Ann Daly Dr Luca Miele Professor Quentin Anstee Professor Helen Reeves et al. | Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease | 2017 |
|
Dr Luca Miele Dr David Sheridan
| Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes | 2016 |
|
Professor Helen Reeves Dr Luca Miele Professor Quentin Anstee
| Telomerase reverse transcriptase mutations are associated with hepatocellular carcinoma in nash | 2015 |
|
Dr Luca Miele Professor Chris Day
| Gut-liver Axis and Microbiota in NAFLD: Insight Pathophysiology for Novel Therapeutic Target | 2013 |
|
Dr Gillian Patman Laura Pascoe Dr Luca Miele Douglas Hui Professor Alastair Burt et al. | Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease | 2012 |
|
Laura Pascoe Dr Luca Miele Professor Helen Reeves
| Kruppel like factor 6 (KLF6) regulates heaptic insulin resistance (HEP-IR) | 2010 |
|
Dr Joseph Gray Dr Dipanker Chattopadhyay Dr Gary Beale Dr Gillian Patman Dr Luca Miele et al. | A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease | 2009 |
|
Dr Gary Beale Ahmad Alserri Dr Luca Miele Dr Gillian Patman Professor Ann Daly et al. | Claudin 10 (CLDN10) - a Candidate Suceptibility Gene for NAFLD Progression | 2009 |
|
Dr Luca Miele Professor Chris Day
| Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease | 2009 |
|
Dr Gary Beale Laura Pascoe Dr Luca Miele Professor Mark Walker Professor Chris Day et al. | The Kruppel-Like Factor 6 (KLF6) Genotype Which is Associated With NAFLD Progression is Associated with Higher Fasting Serum Glucose Levels in Healthy Individuals | 2009 |
|
Dr Luca Miele Dr Gary Beale Dr Gillian Patman Julian Leathart Professor Chris Day et al. | The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease | 2008 |
|
Dr Luca Miele
| Alcoholic and nonalcoholic forms of fatty liver disease | 2007 |
|
Dr Gary Beale Dr Luca Miele Professor Helen Reeves Professor Chris Day
| Differential expression of GSTT1 and GSTT2 is associated with more advanced fibrosis in patients with NAFLD | 2007 |
|
Dr Luca Miele
| Fat in the liver and insulin resistance | 2007 |
|
Dr Luca Miele Dr Gary Beale Julian Leathart Professor Chris Day Professor Helen Reeves et al. | The KLF6 (IVS1-27G > a) polymorphism is associated with non-progressive NAFLD | 2007 |
|